Modeling Cell-Cell Bridging by T-Cell Engagers

From Two Binding Arms to a Cell-Cell Bridge

A T-cell engager can bind an antigen on an effector cell and a different antigen on a tumor cell. When one engager molecule binds both at once, it forms a molecular bridge between the cells. The predicted number of such bridges depends not only on the two arm affinities, but also on the amount of free engager and on how many antigen pairs can physically interact in the cell-cell contact region.

This tutorial builds a deliberately compact, equilibrium model for that calculation. It treats a geometrically compatible effector-antigen/tumor-antigen pair as a local unit that can be empty, occupied by one or two separate engager molecules, or occupied by one molecule bridging both sites. The model is useful for exposing how concentration, antigen density, and contact geometry enter the calculation. Its output is a predicted molecular bridge count, not a prediction of immune synapse duration or cell killing.

The distinction between accessible density and total cellular antigen count matters. A cell may express many antigen molecules overall, while only a subset lies in the contact patch, has an accessible epitope, and has an orientation that permits bridging. Accordingly, \(M\) represents a geometric opportunity count, not automatically the product of the total antigen counts on the two cells.

A Pair-Based Equilibrium Model

For one compatible receptor pair, suppose each antigen can be unoccupied or occupied by an engager arm, and suppose one engager molecule can instead occupy both antigens as a bridge. Let \(C_{\mathrm{eff}}\) be an effective local concentration, in concentration units, that summarizes the geometric and orientational advantage or restriction for binding the second antigen after the first arm has bound. It is a model parameter for the contact configuration, not a change to either intrinsic arm affinity.

Relative to the empty pair, the statistical weights for effector-only occupancy, tumor-only occupancy, and separate occupancy by two engager molecules are \(c/K_E\), \(c/K_T\), and \(c^2/(K_EK_T)\). The weight for one engager bridging both sites is \(cC_{\mathrm{eff}}/(K_EK_T)\). The latter has a single factor of free drug concentration because the two occupied sites are connected by one molecule; \(C_{\mathrm{eff}}\) supplies the concentration factor associated with local second-arm binding.

Here \(Z\) is the sum of the state weights for this pair. Dividing the bridge state's weight by \(Z\) gives the equilibrium probability that a compatible pair is bridged. If the \(M\) compatible pairs are treated as equivalent and independent, the expected bridge abundance is \(M\) times that probability.

The independence assumption is most plausible when compatible pairs are sparse relative to the available antigens, so that one bridge rarely prevents another pair from forming. If many possible pairs share the same receptor sites, simply counting each as an independent opportunity can overestimate bridging. In that case, a network model or a model that explicitly tracks free and occupied receptor populations is more appropriate.

Estimating Geometric Pair Opportunities

When a pair count is not measured directly, a simple coarse-grained approximation is to let the opportunity count scale with both accessible densities and the contact area:

The parameter \(\kappa\) has units of area and summarizes how close and well-oriented two antigens must be to count as a compatible pair. This expression is a sparse-pair approximation: it should not be interpreted as creating unlimited independent pairs when receptor densities become high. It is reasonable only when the resulting opportunities are small relative to the available sites and when \(\kappa\) is supported by structural knowledge, imaging, or calibration.

The density dependence therefore enters through two distinct quantities. Antigen densities determine the number of potential receptor pairs, while \(K_E\), \(K_T\), and \(C_{\mathrm{eff}}\) determine the occupancy probability of each pair. Increasing density does not alter intrinsic affinity in this model; it changes the number of available geometric opportunities.

Comparing Concentration and Antigen-Density Conditions

A dose is not the same quantity as free concentration at the cell interface. Drug distribution, target binding, and elimination determine the relationship between administered dose and \(c\). The calculations below therefore compare specified free concentrations rather than infer local concentrations from administered amounts.

Derivation and Checks on the Model

The bridge probability follows directly from equilibrium state weights. For a receptor pair, a single occupied site has association weight \(c/K\), because \(K\) is a concentration and the ratio is dimensionless. If the two sites are occupied by different engager molecules, the two binding contributions multiply, giving \(c^2/(K_EK_T)\). For one molecule to bind both sites, the first binding contributes \(c/K_E\), while local second-arm binding contributes \(C_{\mathrm{eff}}/K_T\). Their product is \(cC_{\mathrm{eff}}/(K_EK_T)\). Normalizing every state weight by their sum yields the probability above.

Several limiting checks help detect implementation errors. All terms in \(Z\) must be dimensionless and nonnegative, and \(Z\) must be at least one. Since the bridge weight is one of the terms in \(Z\), \(0\leq p_{\mathrm{bridge}}\leq1\); consequently, \(0\leq B\leq M\). If \(c=0\), the bridge weight is zero and \(B=0\). If \(M=0\), no bridges are predicted regardless of concentration. These checks are necessary but do not establish that the biological assumptions are adequate.

A practical diagnostic is to compare the estimated \(M\) with the number of accessible antigens in the contact patch, \(A\sigma_E\) and \(A\sigma_T\). If \(M\) approaches or exceeds either count, the independent-pair interpretation is strained. Also inspect whether plausible changes in \(\kappa\) or \(C_{\mathrm{eff}}\) produce large changes in \(B\). Strong sensitivity signals that geometry needs measurement or calibration rather than an arbitrary fixed value.

Alternatives, Limitations, and Common Mistakes

A simpler alternative is to compute each arm's solution-like occupancy separately and multiply the two occupancies. That can be a rough screening calculation, but it does not by itself represent a single engager molecule connecting two cells, nor does it account for local second-arm geometry or competition from separate molecules. At the other extreme, a detailed state-based binding network can track free antigens, singly bound intermediates, bridged complexes, and receptor depletion explicitly. Such a model is preferable when occupancy is high or pairs share receptors, but it needs more kinetic, geometric, and cellular information. The pair model is a transparent middle ground, not a substitute for those details when they matter.

Equilibrium is another limitation. If binding, dissociation, cell contact, or receptor movement occurs on a similar timescale, the equilibrium count may not describe the transient bridge abundance. The model also does not represent spatial clustering, heterogeneous antigen expression, multivalent binding beyond the two arms, internalization, or downstream signaling. Those processes require additional model structure and data.

• Wrong: “There are 1,000 antigens on one cell and 2,000 on the other, so there are 2,000,000 bridges.” Correction: Antigen counts are not bridge counts. Only accessible, geometrically compatible pairs can bridge, and each pair has a probability of being in the bridged state.
• Wrong: “The administered dose is \(5\ \mathrm{nM}\), so I can use \(c=5\ \mathrm{nM}\).” Correction: Dose and local free concentration are different quantities. Use a PK or exposure model, or an explicit measurement, to obtain the relevant \(c\).
• Wrong: “A larger predicted bridge count proves stronger cell killing.” Correction: This calculation predicts molecular bridges only. Functional activity depends on additional processes not included here.